Discussions

The development of Non-IgG Antibodies Product marks a significant advancement in therapeutic antibody engineering. Unlike traditional IgG-based antibodies, non-IgG antibodies offer unique structural and functional properties that enhance their stability and efficacy in various medical applications. These innovative products expand the possibilities for targeted therapies, particularly in cases where traditional antibodies may face limitations such as size constraints or immune system evasion. By exploring new classes of antibodies, researchers can create more versatile and potent therapeutic options, ultimately driving progress in the treatment of complex diseases.